Macquarie Group LTD Scholar Rock Holding Corp Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.33 - $11.3 $2,137 - $4,531	-401 Reduced 35.39%	732 $8,000
Q3 2021 Nov 12, 2021	SELL	$27.38 - $42.21 $53,226 - $82,056	-1,944 Reduced 63.18%	1,133 $37,000
Q2 2021 Aug 13, 2021	BUY	$26.34 - $46.62 $64,717 - $114,545	2,457 Added 396.29%	3,077 $89,000
Q1 2021 May 14, 2021	SELL	$45.96 - $68.02 $8,732 - $12,923	-190 Reduced 23.46%	620 $31,000
Q2 2020 Aug 11, 2020	BUY	$10.37 - $20.64 $8,399 - $16,718	810 New	810 $15,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.